Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Emami - Good execution continues - ICICI Securities

Posted On: 2021-01-27 22:46:02 (Time Zone: Arizona, USA)


Q3 volumes grew 13% with broad-based performances across the brands. Highlights - (1) healthcare portfolio continued to grow well (+38% YoY) supported by new launches and demand tailwinds, (2) strong performance of winter portfolio leading to 21% growth in BoroPlus range (5% if we combine 2Q and 3Q - to remove the timing mismatch impact), and (3) Fair & Handsome returned to growth trajectory driven by the brand relaunch with fresh packaging, communication and strategy (on a lower base though). We especially like the plans (and ability) of higher ad-spends to support new launches (margins are at an all-time high), comparatively better investment behind Modern Trade and e-commerce, entry into larger categories like Home Care (Emasol) and increasing rural distribution reach. Promoter pledged declined to ~39% from ~47% in Q3FY21 largely due to increase in share prices. Maintain ADD.

- Strong performance across portfolio: Consolidated revenue / EBITDA / recurring PAT grew 15% / 29% / 28%. Domestic revenue and volume grew 16% and 13% while international business revenue grew 26%. This strong performance in domestic business was broad based with 38% YoY growth in health & hygiene portfolio (~47% of business) and 21% growth in BoroPlus range (benefitting from spillover of sales from 2Q). Rest of the portfolio also witnessed strong growth - Pain management (+12%), Kesh King (+16%), 7 Oils in One (+32%), Male grooming range (+5%). Navratna range declined by 12% due to strong winter season. Rural grew ahead of urban. Further, Modern Trade grew by 51%.

- Margin expansion driven by benign input prices, cost savings: Gross margin expanded 210bps YoY to 70.4% driven by benign input costs and favorable mix. EBITDA margin also expanded 390bps YoY to 36.4% driven by lower ad-spends (- 40bps), staff costs (-100bps) and other opex (-40bps). Emami expects margin to remain in similar range driven by benign input prices and cost saving initiatives. However, it expects ad-spends to increase as it would like to invest behind some of the growing brands which could impact margins by ~100bps.

- Other highlights: (1) Launched 30+ new products and 60+ SKUs during 9MFY21, NPD now contributes ~4% in 9MFY21, (2) Launched EMASOL home hygiene range, (3) Chyawanprash and Honey grew ~24% and 2.5x, and (4) Promoter pledged declined to ~39% from ~47% in Q3FY21 largely due to increase in stock prices.

- Valuation and risks: We increase our FY22 earnings estimates by 6%; modelling revenue / EBITDA / PAT CAGR of 8 / 12 / 20 (%) over FY20-23E. Maintain ADD with a DCF-based revised target price of Rs540 (was Rs520). At our target price, the stock will trade at 27x P/E multiple March'23E. Key downside risk is prolonged slowdown in rural demand.

Shares of EMAMI LTD. was last trading in BSE at Rs.482.55 as compared to the previous close of Rs. 484.95. The total number of shares traded during the day was 64163 in over 1755 trades.

The stock hit an intraday high of Rs. 490 and intraday low of 466.2. The net turnover during the day was Rs. 30933852.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk

Initiating Coverage - Mastek Ltd - HDFC Securities Retail Research Desk

Hindalco Industries - Status quo maintained - ICICI Securities

Tata Motors - India business scaling in the right direction - ICICI Securities

IPO Review - Heranba Industries Ltd



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020